Tert-butyl (2-oxo-2,3-dihydrobenzimidazol-1-yl)acetate → [3-(2-Methoxy-2-oxoethyl)-4,6-dimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl]acetic acid
Reaktionsgleichung
O=C1N(CC(OC(C)(C)C)=O)C2C=CC=CC=2N1.C([O:23][C:24](=[O:43])[CH2:25][N:26]1[C:30]2[CH:31]=[C:32]([CH3:36])[CH:33]=[C:34]([CH3:35])[C:29]=2[N:28]([CH2:37][C:38]([O:40][CH3:41])=[O:39])[C:27]1=[O:42])(C)(C)C>>[CH3:41][O:40][C:38](=[O:39])[CH2:37][N:28]1[C:29]2[C:34]([CH3:35])=[CH:33][C:32]([CH3:36])=[CH:31][C:30]=2[N:26]([CH2:25][C:24]([OH:43])=[O:23])[C:27]1=[O:42]Komponenten
3
Versuchsvorschrift
Essentially following the procedures described for Intermediate 7, but using tert-butyl [3-(2-methoxy-2-oxoethyl)-4,6-dimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl]acetate from Step C in place of tert-butyl (2-oxo-3-pyridin-2-yl-2,3-dihydro-1H-benzimidazol-1-yl)acetate, the title compound was prepared. MS: m/z=293 (M+1).
Quellen und Nachweise
- ORD-Eintrag
- ord-56a554181e27490c8669380d3a2df828
- Quelldatensatz
- uspto-grants-2011_08
- Patentnummer
- US08003792B2
Notizen zur Reaktion
Wird geladen…